Phenylisobutylamine
Phenylisobutylamine, also known as _-ethylphenethylamine, is a chemical compound belonging to the class of phenethylamines. It is structurally related to amphetamines and is of interest in the study of neurotransmitter systems and potential pharmacological effects.
Chemical Structure[edit]
Phenylisobutylamine is characterized by its phenethylamine backbone, with an ethyl group attached to the alpha carbon. This structural modification distinguishes it from other phenethylamines such as amphetamine and methamphetamine. The presence of the ethyl group influences its pharmacokinetics and pharmacodynamics.
Pharmacology[edit]
Phenylisobutylamine acts primarily as a central nervous system stimulant. It is believed to exert its effects by promoting the release of monoamine neurotransmitters such as dopamine, norepinephrine, and serotonin. This mechanism is similar to that of other stimulants, although the specific binding affinities and release profiles may vary.
Potential Uses[edit]
While phenylisobutylamine itself is not widely used in clinical practice, its structural similarity to other phenethylamines makes it a compound of interest in research settings. It may serve as a lead compound for the development of new therapeutic agents targeting neurological disorders or as a tool in neuroscience research.
Safety and Legal Status[edit]
The safety profile of phenylisobutylamine is not well-documented, and it is not approved for medical use. Its legal status varies by jurisdiction, and it may be subject to regulation under controlled substances laws due to its potential for abuse and similarity to other stimulants.
Related Compounds[edit]
Phenylisobutylamine is related to a number of other phenethylamines, including:
Related Pages[edit]
-
Phenylisobutylamine
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian